Home > Financial Ratios > JAGSONPAL PHARMACEUTICALS

JAGSONPAL PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
JAGSONPAL PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for JAGSONPAL PHARMACEUTICALS
Please provide your vote to see the results

JAGSONPAL PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 83.21-18.9040.1821.22112.25

What is the latest Core EBITDA Growth ratio of JAGSONPAL PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of JAGSONPAL PHARMACEUTICALS is 83.21 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar202583.21
Mar2024-18.90
Mar202340.18
Mar202221.22
Mar2021112.25

How is Core EBITDA Growth of JAGSONPAL PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 83.21
Positive
Mar2024 -18.9
Negative
Mar2023 40.18
89.35
Mar2022 21.22
-81.10
Mar2021 112.25 -

Other Financial Ratios of JAGSONPAL PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of JAGSONPAL PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
JAGSONPAL PHARMACEUTICALS ₹1,345.7 Cr 1.1% 2.1% -23.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹416,884.0 Cr -0.5% -1.9% -3% Stock Analytics
DIVIS LABORATORIES ₹172,442.0 Cr 1.8% 1.3% 10.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹129,770.0 Cr 1.3% 2.7% 10% Stock Analytics
CIPLA ₹120,871.0 Cr -0.2% -0.7% 1.9% Stock Analytics
DR REDDYS LABORATORIES ₹105,693.0 Cr -1% 2.5% -4.4% Stock Analytics


JAGSONPAL PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
JAGSONPAL PHARMACEUTICALS

1.1%

2.1%

-23.2%

SENSEX

1%

0.6%

7.8%


You may also like the below Video Courses